| Literature DB >> 31473654 |
Abstract
In a recent publication, I argued that there is a conceptual difference between artificial womb (AW) technology, capable of facilitating gestation ex utero, and neonatal intensive care, providing incubation to neonates born prematurely. One of the reasons I provided for this distinction was that the subjects of each process are different entities. The subject of the process of gestation ex utero is a unique human entity: a 'gestateling', rather than a fetus or a newborn preterm neonate. Nick Colgrove wrote a response to my paper, claiming that my distinction between the subject of an AW and a newborn (in intensive care) was false. He claims that I have not accounted for the proper definition of 'birth' and that gestatelings are not a distinct product of human reproduction. Further, Colgrove posits that even if I can successfully distinguish gestatelings from preterms, such a distinction is morally irrelevant because the entities would have the same moral status. In this paper, I address the three challenges raised and defend the claim that gestatelings are unique entities. Moreover, I argue that moral status should not be considered ipso facto determinative in the debate about AWs. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.Entities:
Keywords: embryos and fetuses; ethics; moral status; newborns and minors; reproductive medicine
Mesh:
Year: 2019 PMID: 31473654 PMCID: PMC6860405 DOI: 10.1136/medethics-2019-105723
Source DB: PubMed Journal: J Med Ethics ISSN: 0306-6800 Impact factor: 5.926